Lindbrook Capital’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,562	Closed	-$11K	–	2730
2022 Q1	$11K	Buy	1,562 +1,471	+1,616%	+$10.4K	﹤0.01%	1258
2021 Q4	$1K	Buy	+91	New	+$1K	﹤0.01%	1974